The gemfibrozil cost-benefit model
An edition of The gemfibrozil cost-benefit model (1993)
analysis of data from the Helsinki Heart Study, model development and extension to the California medicaid population
By Syam Sarma
Publish Date
1993
Publisher
Rand
Language
eng
Pages
139
Description:
subjects: Coronary heart disease, Treatment, Medicaid, Prevention, Statistics, Economics, Gemfibrozil, Therapeutic use, Cost effectiveness, Digoxin, Mathematical models, Hyperlipidemia, Costs, Coronary Disease, Risk factors, Cost-Benefit Analysis, Drug therapy
Places: California, Finland, United States